Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
- 1 May 2009
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 9 (4) , 425-434
- https://doi.org/10.2174/156652409788167113
Abstract
Hypoxia or oxygen deficiency is a salient feature of solid tumors. Hypoxic tumors are often resistant to conventional cancer therapies, and tumor hypoxia correlates with advanced stages of malignancy. Hypoxic tumors appear to be poorly differentiated. Increasing evidence suggests that hypoxia has the potential to inhibit tumor cell differentiation and thus plays a direct role in the maintenance of cancer stem cells. Studies have also shown that hypoxia blocks differentiation of mesenchymal stem/progenitor cells, a potential source of tumor-associated stromal cells. It is therefore likely that hypoxia may have a profound impact on the evolution of the tumor stromal microenvironment. These observations have led to the emergence of a novel paradigm for a role of hypoxia in facilitating tumor progression. Hypoxia may help create a microenvironment enriched in poorly differentiated tumor cells and undifferentiated stromal cells. Such an undifferentiated hypoxic microenvironment may provide essential cellular interactions and environmental signals for the preferential maintenance of cancer stem cells. This hypothesis suggests that effectively targeting hypoxic cancer stem cells is a key to successful tumor control.Keywords
This publication has 99 references indexed in Scilit:
- Stromal fibroblasts in cancer initiation and progressionNature, 2004
- EPAS1 Promotes Adipose Differentiation in 3T3-L1 CellsJournal of Biological Chemistry, 2004
- Brain and cancer: The protective role of erythropoietinMedicinal Research Reviews, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profilingOncogene, 2000
- Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1αGenes & Development, 1998
- Molecular Characterization of the Novel Basic Helix–Loop–Helix Protein DEC1 Expressed in Differentiated Human Embryo ChondrocytesBiochemical and Biophysical Research Communications, 1997
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Distribution of involucrin in normal and pathological human uterine cervixGynecologic Oncology, 1990